Ask questions and gain insights about this stock now with Rize AI
PFE logo

Pfizer Inc.

PFE

Stock Analysis

$24.19

+0.00 (+0.00%)• Live

Pfizer Inc. Analysis Dashboard - Stock Analysis and Financial Metrics

Historical Prices

for Pfizer Inc.

Key Financial Metrics

for Pfizer Inc.

2024 FY
P/E Ratio
17.66
Revenue Growth
+8.77%
EPS Growth
+273.68%
Market Cap
$139.18B
Dividend Yield
+6.94%
Debt/Equity
0.68
ROIC
+8.97%
FCF Yield
+6.79%
View additional metrics

Valuation

P/B Ratio1.54
EV/Sales3.19

Financial Health

Current Ratio1.26
Return on Assets+9.19%

Analyst Recommendations

for Pfizer Inc.

37 analysts
Consensus: Hold

About

for Pfizer Inc.

Company Details

for Pfizer Inc.

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Albert Bourla

Employees

81,000

Market Cap

137.53B

Exchange

New York Stock Exchange

IPO Date

June 1, 1972

CIK

0000078003

ISIN

US7170811035

CUSIP

717081103

Country

US

Balance Sheet

for Pfizer Inc.

Cash Flow Statement

for Pfizer Inc.

Income Statement

for Pfizer Inc.

Rize ist ein KI-gestütztes Investment-Research-Terminal, das eine umfassende Aktienanalyse und Einblicke über ein intuitives Dashboard bietet.

News

No news available at the moment.